Global Down syndrome market Is Projected To Witness Vigorous Expansion By 2026 | OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S, AC Immune
The reliable Global Down Syndrome Market report also explains an in depth description, competitive scenario, wide product portfolio of key vendors and their business strategies with the help of SWOT analysis and porter's five force analysis. The market drivers and restraints have been explained specifically in the report. The statistics are indicated in graphical format in the report for a clear understanding of facts and figures. The report entails a variety of steps for gathering, recording and analysing data. A persuasive Global Down Syndrome Market report assesses the potential market for a new product to be introduced in the market.
Global Down syndrome market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. The high prevalence of Down syndrome, increasing governmental funding for development of novel therapies and rising awareness about the disease are the major drivers for the market growth.
Get Sample Report + All Related Graphs & Charts @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-down-syndrome-market
Global Down syndrome market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global Down syndrome market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Players:
Few of the major competitors currently working in the global down syndrome market are OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S, AC Immune, Advocate Health Care, Inc., Annovis Bio, Inc., ManRos Therapeutics, Pfizer Inc., Eisai Co., Ltd., Balance Therapeutics, Bayer AG, Genentech, Inc., Promega Corporation, Johnson & Johnson Services, Inc., Lonza, ALLERGAN, Cognition Therapeutics, Inc., Zynerba Pharmaceuticals, Inc., ProMIS Neurosciences, Ligand Pharmaceuticals Incorporated among others.
Global Down Syndrome Market By Disease Type (Trisomy 21, Translocation Down Syndrome, Mosaic Down Syndrome, Others), Test Type (Screening Tests, Diagnostic Tests, Others), Route of Administration (Oral, Injectable and Others), End Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) - Industry Trends and Forecast to 2026
Down syndrome is also known as trisomy 21. It is a genetic disorder characterized by lifelong mental retardation, poor muscle tone and muscular hypotonia. There are several symptoms observed in children with Down Syndrome which includes larger tongue, poor muscle tone, short fingers, small facial features among others.
The incidence of Down syndrome is estimated to be 1 case in 800 live births. The increase of life span in past few decades has resulted in the high prevalence rate of Down syndrome.
High prevalence rate of down syndrome and other related disorders are major drivers for the market growth
Introduction of novel therapies and enhancing research and development for the treatment and management of down syndrome acts as a market driver in the forecast period
Increasing investments form government for drug development and advanced diagnostic procedures for down syndrome will also boost the market growth
Rising awareness about the disease and its complications drives the market growth
Unavailability of any specific treatment is one of the major factor that can hamper the growth of this market
Stringent regulatory approval for new drugs can also restrict the market growth
Side effects associated with Down syndrome treatment therapies will hinder the growth of this market
Grab Your Report at an Impressive Discount! Please click Here@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-down-syndrome-market
Key Developments in the Market:
In September 2019, the National Institutes of Health (NIH) awarded a grant of approximately USD35 million to its research and development project to conduct an advanced research on Down syndrome. This project of NIH is called the Investigation of Co-occurring Conditions Across the Lifespan to Understand Down Syndrome (INCLUDE) project. The main purpose of this project is to investigate the critical health conditions and needs of people suffering from Down syndrome. Additionally, the research will also focus on co-occurring conditions with people who are not suffering from Down syndrome
In August 2016, OPKO Health, Inc. announced acquisition of Transition Therapeutics, Inc. The acquisition includes ELND005, a CNS drug candidate used for treatment of patients with Down syndrome and Alzheimer's disease. The purpose of this deal was to acquire the business and pipeline drugs of Transition Therapeutics, Inc. This acquisition gives the right to develop and commercialize the drug product in order to benefit the business development
Reasons to Purchase this Report
Current and future of global down syndrome market outlook in the developed and emerging markets
The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
Regions/Countries that are expected to witness the fastest growth rates during the forecast period
The latest developments, market shares, and strategies that are employed by the major market players
Data Bridge Market Research
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Down syndrome market Is Projected To Witness Vigorous Expansion By 2026 | OPKO Health, Inc., LuMind IDSC Foundation, MIT Alana Center, H. Lundbeck A/S, AC Immune here
News-ID: 2151897 • Views: 1030
More Releases from Data Bridge Market Research
Artificial Intelligence Market 2021 is Booming Worldwide with Key Players like …
Artificial Intelligence market report is presented to the clients that extend their reach to success. Market parameters covered in this advertising report can be listed as market definition, currency and pricing, market segmentation, market overview, premium insights, key insights and company profile of the key market players. Each parameter included in this business research report is again explored deeply for the better and actionable market insights. Geographical scope of the
Traction Battery Market 2021 is Booming Worldwide with Key Players GS Yuasa Inte …
Traction Battery market report also recognizes and analyses the growing trends along with major drivers, restraints, challenges and opportunities in the industry. This finest market research document has been structured with the expertise and innovation of a team of researchers, forecasters, analysts and managers. The report acts as a supreme base for the competitor analysis, analyzing their core competencies, and drawing a competitive landscape for the industry. Traction Battery market
Tablet Kiosk Market To See Astonishing Growth | Leading Players Are Calista, Ar …
Tablet Kiosk is a professional and a meticulous report which focuses on primary and secondary drivers, market share, leading segments and geographical analysis. It endows with an analytical measurement of the main challenges faced by the business currently and in the upcoming years. This market research report offers an insightful market data and information about industry to businesses for making better decisions and defining business strategies. The Tablet Kiosk report
Building Analytics Market To See Astonishing Growth | Leading Players Are ENG …
Building Analytics Market Research Report 2021 is latest research study released by Data Bridge Market Research evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. Building Analytics market research report reviews diverse markets at a global level in accord with the client’s requirements and scoop out the best possible solutions and detailed information about the market trends. This particular market report is a source of
More Releases for Syndrome
Carcinoid Syndrome Diarrhea Treatment Market
Increasing prevalence of rare carcinoid syndrome diarrhea to boost market growth According to the National Organization for Rare Disorders (NORD), 2017, each year, only 27 individuals per million population are estimated to be diagnosed with carcinoid tumors in the U.S., amongst whom, only 10% individuals develop carcinoid syndrome. Moreover, it affects both males and females in equal number. Increasing prevalence of the disease is in turn, increasing demand for carcinoid syndrome
Carcinoid Syndrome Diarrhea Treatment Market
Carcinoid syndrome is caused by secretion of certain harmful chemicals by carcinoid tumors. Carcinoid syndrome may occur due to infection or other related diseases, and medical or surgical treatments such as anesthesia, chemotherapy, embolization, and tumor debulking. The key symptoms of the syndrome include flushing of the skin and diarrhea, rapid heartbeat, and bronchoconstriction. If remained undiagnosed, it could lead to several complications such as weight loss, electrolyte imbalance, dehydrations,
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H2 2017, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline landscape. Gorlin syndrome, also known as nevoid
Familial Chylomicronemia Syndrome Treatment Market
Familial Chylomicronemia Syndrome is a genetic condition characterized by an inability of the body to digest fats mainly triglyceride. In Familial Chylomicronemia Syndrome, the lipoprotein lipase (LPS) is not functional, which is the enzyme that breaks down chylomicrons in the blood. The most distinctive sign of Familial Chylomicronemia Syndrome is the appearance of fatty blood on the skin, mainly owing to high level of fat in the body. People with
Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017
ReportsWeb.com published “Gorlin Syndrome Market” from its database. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Original Content: Publisher's latest Pharmaceutical and Healthcare disease pipeline guide Gorlin Syndrome (Basal Cell Nevus Syndrome) - Pipeline Review, H1 2017, provides an overview of the Gorlin Syndrome (Basal Cell Nevus Syndrome) (Genetic Disorders) pipeline landscape. Gorlin
Global Acute Coronary Syndrome Market
The Acute Coronary Syndrome Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Acute coronary syndrome is one of the serious medical conditions characterized by sudden and reduced flow of blood to the heart. The symptoms of acute coronary syndrome are the same